MOESM2 of Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report
2018-02-06T05:00:00Z (GMT) by
Additional file 2: Figure S2. Activation markers expressed by vaccine-reactive T cell clones at IM3. T cells responding to vaccine peptide stimulation with IFN-Îł+ production were analyzed for their expression of the activation markers CD25, CD69 and HLA-DR by flow cytometry.